Milestone Pharmaceuticals said on Friday the U.S. health regulator had declined to approve its nasal spray to treat a type of ...
13 小时
Stocktwits on MSNMilestone Pharmaceuticals Stock Plunges 60% After FDA Declines To Approve Its Cardamyst ...Shares of Milestone Pharmaceuticals Inc. (MIST) traded 60% lower on Friday after the Food and Drug Administration (FDA) did ...
I tested the Kopari Sunglaze transparent Setting Mist for several days and talked about it with the chemists at the Good ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果